Article
Prognostic value of CA20, a score based on centrosome amplification-associated genes, in breast tumors
15 Mar 2017
Abstract excerpt
Centrosome amplification (CA) is a hallmark of cancer, observable in ≥75% of breast tumors. CA drives aggressive cellular phenotypes such as chromosomal instability (CIN) and invasiveness. Thus, assessment of CA may offer insights into the prognosis of breast cancer and identify patients who might benefit from centrosome declustering agents. However, it remains unclear whether CA is correlated with clinical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
